What is the recommended evaluation and management for an actively bleeding anal fissure?

Management of Actively Bleeding Anal Fissure

For an actively bleeding anal fissure, begin with conservative management including fiber supplementation, adequate fluid intake, sitz baths, and topical analgesics, as bleeding from anal fissures is characteristically bright red and scanty, and approximately 50% of fissures heal with this approach alone. 1

Initial Evaluation

Clinical Diagnosis

• Suspect the diagnosis based on history alone: patients typically report bright red, scanty bleeding on toilet paper or in the toilet bowl, accompanied by severe anal pain during and after defecation 1
• Confirm diagnosis by visual inspection: efface the anal canal with opposing traction on the buttocks to visualize the fissure as a split in the squamous epithelium at or just inside the anal verge 1
• Avoid instrumentation if marked pain is present: endoscopy is traumatic to the patient and rarely yields diagnostic information in the acute setting 1

Red Flags Requiring Further Investigation

• Off-midline location mandates evaluation for underlying conditions including Crohn's disease, HIV/AIDS, ulcerative colitis, tuberculosis, syphilis, leukemia, or cancer 1
• Consider colonoscopy for: increased age, family history of colorectal neoplasia, persistent bleeding despite treatment, weight loss, or iron deficiency anemia 2
• In low-risk patients under 40 years with midline fissures and minimal bleeding, clinical evaluation plus rectoscopy may be sufficient, as adenomatous polyps were found in only 3% and no adenocarcinomas were identified in this population 3

Treatment Algorithm

First-Line Conservative Management (Appropriate for Most Cases)

• Fiber supplementation to soften stool and reduce mechanical trauma 1, 4, 5
• Adequate fluid intake to maintain soft stool consistency 1
• Sitz baths for symptomatic relief 1
• Topical analgesics for pain control 1
• Acute fissures are more likely to heal with conservative care alone compared to chronic fissures 1

Second-Line Pharmacological Therapy (If Conservative Care Fails After 6-8 Weeks)

Topical calcium channel blockers are preferred over nitroglycerin as first-line pharmacological therapy due to similar efficacy but fewer side effects and better patient compliance 5, 6

• Topical 0.3% nifedipine plus 1.5% lidocaine is recommended for chronic anal fissures 5
• Topical nitroglycerin (GTN) has healing rates of 25-50% but causes headaches that may limit compliance 1
• Botulinum toxin injection shows cure rates of 75-95% with low morbidity, though optimal injection location remains controversial 1, 2

Surgical Management (Third-Line or for Severe Cases)

Lateral internal sphincterotomy (LIS) remains the gold standard surgical treatment with success rates exceeding 90%, rapid symptom relief, high cure rates, and low relapse rates 1, 7, 8

• LIS is indicated for: chronic fissures failing 6-8 weeks of topical therapy, severe pain intolerable for conservative care, or recurrent fissures despite optimal medical treatment 1, 7
• Important caveat: LIS carries a risk of minor but sometimes permanent continence defects in a minority of patients 1, 9
• Fissurectomy with anoplasty is preferred in some European countries (particularly Germany and France) due to lower incontinence risk, with success rates around 80% 7, 8
• Fissurectomy with flap advancement may be guided by clinical findings, endoanal ultrasound, and anal manometry 5

Key Clinical Pitfalls

• Do not perform forceful anal examination in patients with severe pain, as this is traumatic and rarely diagnostic; consider examination under anesthesia if diagnosis cannot be made comfortably 1
• Do not use forcible uncalibrated anal dilatation, as this technique is no longer recommended due to high complication rates 7
• Recognize that most fissures occur in the posterior midline (79%), with anterior fissures accounting for 20%; off-midline location requires investigation for secondary causes 3
• Balance surgical effectiveness against continence risks: while LIS is most effective long-term, the risk of irreversible incontinence must be weighed, particularly in patients with pre-existing sphincter weakness 7, 9, 8

Emerging Therapies

Recent evidence suggests platelet-rich plasma (PRP), adipose-derived regenerative cells (ADRCs), and percutaneous tibial nerve stimulation (PTNS) show promising results as potential alternatives for chronic anal fissures, though these remain investigational 6